Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - ACCOUNTS PAYABLE
Accounts Payable REGN - Regeneron Pharmaceuticals, Inc.
790 M
LAST VALUE
15.76%
2 YEAR CAGR
13.56%
5 YEAR CAGR
23.01%
10 YEAR CAGR